118 related articles for article (PubMed ID: 8388656)
1. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells.
Gräfe M; Bossaller C; Graf K; Auch-Schwelk W; Baumgarten CR; Hildebrandt A; Fleck E
Am J Physiol; 1993 May; 264(5 Pt 2):H1493-7. PubMed ID: 8388656
[TBL] [Abstract][Full Text] [Related]
2. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH; Busse R
Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
[TBL] [Abstract][Full Text] [Related]
3. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelium-derived bradykinin in the control of vascular tone.
Hecker M; Dambacher T; Busse R
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
[TBL] [Abstract][Full Text] [Related]
5. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitor effect on bradykinin metabolism in the vascular wall.
Gohlke P; Bünning P; Bönner G; Unger T
Agents Actions Suppl; 1992; 38 ( Pt 3)():178-85. PubMed ID: 1462857
[TBL] [Abstract][Full Text] [Related]
8. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
Wiemer G; Schölkens BA; Becker RH
Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
Wiemer G; Popp R; Schölkens BA; Gögelein H
Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
11. Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells.
Graf K; Gräfe M; Bossaller C; Niehus J; Schulz KD; Auch-Schwelk W; Fleck E
Eur J Clin Chem Clin Biochem; 1993 May; 31(5):267-72. PubMed ID: 8395230
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
Cardiovasc Res; 1993 Feb; 27(2):312-7. PubMed ID: 8386065
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
14. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Baudin B; Drouet L
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression.
Soehnlein O; Schmeisser A; Cicha I; Reiss C; Ulbrich H; Lindbom L; Daniel WG; Garlichs CD
J Vasc Res; 2005; 42(5):399-407. PubMed ID: 16088213
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin degrading activity in cultured human endothelial cells.
Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells.
Busse R; Lamontagne D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.
Blais C; Fortin D; Rouleau JL; Molinaro G; Adam A
J Pharmacol Exp Ther; 2000 Nov; 295(2):621-6. PubMed ID: 11046097
[TBL] [Abstract][Full Text] [Related]
19. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
